TipRanks
Fennec Pharmaceuticals (DE:RV41)
FRANKFURT:RV41
Germany Market
RV41
Fennec Pharmaceuticals
RESEARCH TOOLSreports

Fennec Pharmaceuticals (RV41) Income Statement

0 Followers

Fennec Pharmaceuticals Income Statement

Last quarter (Q2 2026), Fennec Pharmaceuticals's total revenue was $17.87M, an increase of 85.18% from the same quarter last year. In Q2, Fennec Pharmaceuticals's net income was $1.97M. See Fennec Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 44.64M$ 47.54M$ 21.25M$ 1.53M$ 0.00
Gross Profit
$ 40.88M$ 44.35M$ 19.99M$ 1.45M$ 0.00
Operating Expenses
$ 47.22M$ 41.88M$ 33.05M$ 24.19M$ 17.22M
Depreciation and Amortization
$ 103.00K$ 800.00K$ 287.00K$ 149.00K$ 16.00K
EBITDA
$ -7.45M$ 4.80M$ -12.36M$ -22.59M$ -17.22M
Operating Income
$ -6.35M$ 2.48M$ -13.06M$ -22.74M$ -17.22M
Other Income/Expenses
$ -3.29M$ -2.55M$ -2.99M$ -976.00K$ -123.00K
Pretax Income
$ -9.63M$ -71.00K$ -16.05M$ -23.71M$ -17.35M
Net Income
$ -9.74M$ -436.00K$ -16.05M$ -23.71M$ -17.35M
Per Share Metrics
Basic EPS
$ -0.36$ -0.02$ -0.60$ -0.95$ -0.67
Diluted EPS
$ -0.36$ -0.02$ -0.60$ -0.95$ -0.67
Weighted Average Shares Outstanding
 28.58M 27.29M 26.57M 26.27M 26.01M
Weighted Average Shares Outstanding (Diluted)
 28.58M 27.29M 26.57M 26.27M 26.01M
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History